2mg Bortezomib For Injection

Get a Price/Quote

MOQ : 10 Boxes

2mg Bortezomib For Injection Specification

Dosage Form
Lyophilized Powder for Injection

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Salt Composition
Bortezomib 2mg/vial

Enzyme Types
Proteasome Inhibitor (not an enzyme but inhibits enzymatic activity)

Feature
Highly purified, rapid reconstitution, suitable for oncology use, High purity, single-use vial, sterile product

Ingredients
Bortezomib and mannitol as excipient, Bortezomib, Mannitol

Application
Intravenous or Subcutaneous administration

Ph Level
Neutral pH after reconstitution

Temperature Needed For Fermentation
Not applicable (synthetic preparation, not fermented)

Physical Color/Texture
White to off-white lyophilized powder, White to off-white lyophilized powder

Fermentation Smell
Odorless (no fermentation), Odorless

Enzymatic Activity
Inhibits 26S proteasome activity in cells

Storage Instructions
Store below 25C; protect from light, do not freeze

Shelf Life
24 months from manufacturing date

Manufacturer Approval
WHO-GMP compliant

Prescription Status
Prescription only (Rx)

Packaging Type
Vial, tray pack with insert

Quality Standards
Indian Pharmacopoeia/BP/USP as applicable

Strength
2mg/vial

Reconstitution
To be reconstituted with 0.9% sodium chloride

Contraindications
Hypersensitivity to boron or mannitol

Route of Administration
Intravenous or subcutaneous

Marketed By
As printed on packaging (varies by distributor)

Batch Number & Expiry
Printed on vial and box

2mg Bortezomib For Injection Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 2mg Bortezomib For Injection

Discover a crackerjack solution to cancer therapy with 2mg Bortezomib For Injection, now available as a hot deal with a price cut. This scarce, lustrous lyophilized powder delivers virtuoso results in the management of multiple myeloma and mantle cell lymphoma. Each WHO-GMP compliant vial contains highly purified bortezomib, reconstituted easily with 0.9% sodium chloride for rapid, sterile intravenous or subcutaneous administration. Presented in premium tray packs, the batch number and expiry are clearly printed. A prescription-only, Indian Pharmacopoeia/BP/USP standard product for professional oncology use. Exported and supplied across India, this single-use vial is a trusted anticancer treatment with neutral pH and no odor.

Competitive Edge for Oncology Professionals

2mg Bortezomib For Injection stands out in the oncology domain due to its highly purified, single-use formulation, ensuring safety and efficacy for specialist practitioners. Intended for administration by healthcare virtuosos in oncology, this drug is invaluable in treating multiple myeloma and mantle cell lymphoma. Its rapid reconstitution and compliance with stringent WHO-GMP standards make it an essential addition to hospital and clinical pharmacy stock for prescription use by qualified professionals only.

Sample Availability and Premium Delivery Service

Experience premium quality at the lowest price with sample availability for 2mg Bortezomib For Injection, catering to the main domestic market across India. Each order is swiftly processed and handed over to trusted couriers, ensuring timely delivery. This product is favored by exporters, suppliers, and traders for its reliability and competitive rates. Secure your oncology supplies with confidence, knowing batch and expiry details are included and storage guidelines strictly upheld to preserve integrity.

FAQ's of 2mg Bortezomib For Injection:

Q: How should 2mg Bortezomib For Injection be reconstituted for use?

A: To prepare 2mg Bortezomib For Injection, reconstitute the lyophilized powder using 0.9% sodium chloride. This process results in a neutral pH solution, suitable for intravenous or subcutaneous administration by healthcare professionals.

Q: What are the indications for using 2mg Bortezomib For Injection?

A: This medication is indicated for the treatment of multiple myeloma and mantle cell lymphoma. It should be prescribed and administered under the supervision of qualified oncology practitioners.

Q: When should 2mg Bortezomib For Injection not be used?

A: Bortezomib should not be used in patients who have hypersensitivity to boron, mannitol, or any component of the formulation. Always consult the product insert for a full list of contraindications before prescribing.

Q: Where can healthcare providers source this product in India?

A: 2mg Bortezomib For Injection is available throughout the main domestic market in India and can also be obtained from exporters, suppliers, or traders. The product packaging clearly lists the distributor and marketing details.

Q: What are the storage requirements for this injection?

A: Store the vials below 25C, protected from light, and do not freeze. Proper storage ensures the integrity and potency of the product, which has a shelf life of 24 months from the manufacturing date.

Q: How does Bortezomib function as a cancer treatment?

A: Bortezomib is a proteasome inhibitor, meaning it blocks the 26S proteasome enzymatic activity in cells, which is essential for cancer cell proliferation and survival, thereby helping to control tumor growth.

Tell us about your requirement